Image Credit: drmicrobe/123rf.com A recent clinical trial published in the New England Journal of Medicine has reported promising results for a new drug, bepirovirsen, which has shown a functional cure rate of approximately 19% in patients with chronic hepatitis B. This is a significant improvement compared to the current standard of care, which achieves a…
Image Credit: remyelination/123rf.com A recent doctoral thesis from the University of Helsinki has identified two promising drug candidates that may pave the way for new treatments in multiple sclerosis (MS). Conducted by Tapani Koppinen under the supervision of Associate Professor Merja Voutilainen, the research highlights the potential of these molecules to promote myelin regrowth and…
Image Credit: heitipaves/123rf.com Immunotherapy has significantly transformed cancer treatment over the last decade, but prostate cancer has remained largely unresponsive to these advancements. Researchers have long categorized prostate cancer as “immune-cold,” indicating a lack of immune system recognition and response. However, recent developments involving a new drug, VIR-5500, show promise in changing this narrative. In…
